Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference
Carraway H, Brunner A, Lai C, Luskin M, Park J, Perl A, Stein E, Wang E, Zeidan A, Zeidner J, Komrokji R. Advancing the Management of CH, MDS, and AML From the First Bridging the Gaps in Leukemia, Lymphoma, and Multiple Myeloma Conference. Clinical Lymphoma Myeloma & Leukemia 2025, 25: 583-589. PMID: 40187939, DOI: 10.1016/j.clml.2025.03.005.Peer-Reviewed Original ResearchManagement of myelodysplastic syndromesAcute myeloid leukemiaFrontline treatment of acute myeloid leukemiaTreatment of R/R AMLR/R acute myeloid leukemiaTreatment of acute myeloid leukemiaDevelopment of targeted therapiesSequence of therapyMonitoring of responseManagement of CHAssessment of responseMyelodysplastic syndromeClonal hematopoiesisFrontline treatmentMyeloid leukemiaEffective therapyClinical trialsMolecular testingCare of patientsConsensus recommendationsSelection of endpointsTreatment selectionTherapyPatientsLeukemia
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply